Prognostic nomogram on clinicopathologic features and serum indicators for advanced non-small cell lung cancer patients treated with anti-PD-1 inhibitors

BACKGROUND: Immune checkpoint inhibitors (ICIs) have appeared as a promising therapy regimen for non-small cell lung cancer (NSCLC), but with an unsatisfying therapeutic response and inefficiency of a single predictive biomarker in patients’ selection. METHODS: Central data of clinicopathologic feat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Rong, Fan, Yinxing, Zhao, Jiayi, He, Fan, Li, Jianong, Han, Yiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575979/
https://www.ncbi.nlm.nih.gov/pubmed/33145297
http://dx.doi.org/10.21037/atm-20-4297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575979/
https://www.ncbi.nlm.nih.gov/pubmed/33145297
http://dx.doi.org/10.21037/atm-20-4297

Ejemplares similares